RxDoctor Payments Data

Edward Gage

Physician Assistant · West Columbia, SCNPI 1770672792

Payments from drug & device makers

$4,966in general payments, 2019–2025

Across 153 payments — averaging $32.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • AbbVie$434
  • Tersera Therapeutics LLC$273
  • Forte Bio-pharma LLC$270
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$151
  • Nevro Corp.$120
  • plus $856 from 18 others

What the payments were for

  • Travel & lodging$91018%
  • Food & beverage$3,98480%
  • Education$721%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,966 in reported general payments places this provider in the 90th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$177,670
Medicare patients
251
Services billed
3,770

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate88$70,102
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen988$33,838
OxycontinOxycodone Hcl64$33,750
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen593$14,818
UbrelvyUbrogepant13$12,127
Morphine Sulfate ErMorphine Sulfate280$10,352
Fentanyl100$10,156
LinzessLinaclotide13$8,148
MovantikNaloxegol Oxalate13$6,048
Oxycodone Hcl367$5,894
Buprenorphine16$5,782
Gabapentin278$5,051
Morphine Sulfate119$4,137
Pregabalin225$3,225
Tramadol Hcl ErTramadol Hcl50$2,783

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$42$70,10288 claims
AbbVieUbrelvy, Linzess$434$20,27526 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate, Buprenorphine Hcl$16$10,197150 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in West Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →